Ninjour Health International Limited agreed to acquire Assets of ReShape Lifesciences Inc (NasdaqCM:RSLS) for $5.2 million on July 8, 2024. The consideration is subjected to certain adjustments. The board of directors of ReShape has unanimously approved the transaction.

The transaction is subjected to customary closing conditions including the required approval of a majority of the outstanding shares of commons stock of ReShape. Brett R. Hanson of Fox Rothschild LLP acted as legal advisor and Maxim Group LLC acted as financial advisor to ReShape Lifesciences.